HLB Life Science Co., Ltd. (067630.KQ)
KRW 9780.0
(-1.81%)
KRW 9780.0
(-1.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.01 Billion | -29.74 Billion | -14.08 Billion | 2.01 Billion | -12.38 Billion | -11.07 Billion |
| Net Income | -5.98 Billion | -54.27 Billion | -49.15 Billion | -55.79 Billion | 7.52 Billion | -18.19 Billion |
| Depreciation & Amortization | 7.69 Billion | 4.97 Billion | 2.06 Billion | 1.56 Billion | 1.9 Billion | 345.94 Million |
| Deferred income taxes | - | - | - | - | 8.09 Billion | -2.49 Billion |
| Stock-based compensation | - | - | - | - | 3.54 Million | 24.76 Million |
| Change in working capital | 5.76 Billion | -13.24 Billion | 601.64 Million | 4.93 Billion | -13 Billion | -5.26 Billion |
| Other non-cash items | -17.48 Billion | 32.8 Billion | 32.39 Billion | 51.31 Billion | 388.88 Million | 17.07 Billion |
| Investing Cash Flow | -8.88 Billion | -72.64 Billion | 8.82 Billion | 62.23 Million | 36.7 Billion | -163.51 Billion |
| Investments in PPE | -21.52 Billion | -11.65 Billion | -2.61 Billion | -20.8 Billion | -15.48 Billion | -10.53 Billion |
| Acquisitions | -2.37 Billion | -35.5 Billion | 1.96 Billion | 6.14 Billion | -23 Billion | -848.76 Million |
| Investment purchases | -35.68 Billion | -68.64 Billion | -24.27 Billion | -74.72 Billion | -82.38 Billion | -203.29 Billion |
| Sales/Maturities of investments | 49.47 Billion | 39.25 Billion | 33.35 Billion | 90.52 Billion | 268.86 Billion | 53.31 Billion |
| Other Investing Activities | 1.23 Billion | 3.9 Billion | 388.46 Million | -1.07 Billion | -111.28 Billion | -2.14 Billion |
| Financing Cash Flow | 4.78 Billion | 102.09 Billion | -641.08 Million | -1.68 Billion | -4.39 Billion | 178 Billion |
| Debt repayment | -6.75 Billion | -102.15 Billion | -642.23 Million | -1.26 Billion | -4.11 Billion | -23.72 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -679.97 Million | - | -176.09 Million | - | - | - |
| Common Stock Issuance | 142.27 Million | 459.36 Million | 129.24 Million | 82.59 Million | 643.56 Million | 154.27 Billion |
| Other Financing Activities | 13.64 Billion | 203.79 Billion | 1.15 Million | -498.32 Million | -17.35 Billion | 153.13 Billion |
| Accounts receivables | 4.03 Billion | 9.2 Billion | -1.03 Billion | 26.86 Billion | -7.4 Billion | 3.6 Billion |
| Accounts payables | -4.07 Billion | -5.61 Billion | 4.73 Billion | -21.17 Billion | 3.31 Billion | -7.01 Billion |
| Inventory | 5.3 Billion | -2.51 Billion | 221.34 Million | 5.06 Billion | -1.29 Billion | -942.1 Million |
| Other working capital | 501.09 Million | -14.32 Billion | -3.31 Billion | -5.82 Billion | -7.61 Billion | -908.42 Million |
| Cash at beginning of period | 30.97 Billion | 31.25 Billion | 37.15 Billion | 36.76 Billion | 16.86 Billion | 13.44 Billion |
| Cash at end of period | 16.76 Billion | 30.97 Billion | 31.25 Billion | 37.15 Billion | 36.76 Billion | 16.86 Billion |
| Capital Expenditure | -21.52 Billion | -11.65 Billion | -2.61 Billion | -20.8 Billion | -15.48 Billion | -10.53 Billion |
| Effect of forex changes on cash | -97.04 Million | 15.55 Million | 53.97 Thousand | -1150.00 | -10.12 Million | 10.00 |
| Net cash flow / Change in cash | -14.2 Billion | -275.23 Million | -5.9 Billion | 388.25 Million | 19.9 Billion | 3.41 Billion |
| Free Cash Flow | -31.53 Billion | -41.39 Billion | -16.69 Billion | -18.79 Billion | -27.87 Billion | -21.6 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -144.43 Billion | 145.09 Billion | 6.45 Billion | -5.98 Billion | -16.31 Billion | -9.78 Billion |
| Depreciation & Amortization | 1.48 Billion | 1.59 Billion | 1.75 Billion | 7.69 Billion | 1.93 Billion | 2.05 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.03 Billion | -1.08 Billion | 3.55 Billion | 5.76 Billion | 438.99 Million | -1.45 Billion |
| Other non-cash items | 129.5 Billion | -148.11 Billion | -16.02 Billion | -17.48 Billion | 10.05 Billion | 3.76 Billion |
| Investing Cash Flow | -4.51 Billion | -14.54 Billion | 412.71 Million | -8.88 Billion | -12.35 Billion | 7.32 Billion |
| Investments in PPE | -9.86 Billion | -4.54 Billion | -9.16 Billion | -21.52 Billion | -4.7 Billion | -4.12 Billion |
| Acquisitions | 449.07 Million | 14.9 Million | 6.41 Billion | -2.37 Billion | -8.01 Billion | -815.08 Million |
| Investment purchases | -44.27 Million | -5.81 Billion | -19.13 Billion | -35.68 Billion | -6.01 Billion | -5.26 Billion |
| Sales/Maturities of investments | 166.49 Million | 2.44 Billion | 20.86 Billion | 49.47 Billion | 8.76 Billion | 16.25 Billion |
| Other Investing Activities | 4.9 Billion | -6.63 Billion | 1.43 Billion | 1.23 Billion | -2.38 Billion | 1.28 Billion |
| Financing Cash Flow | 11.53 Billion | 58.8 Billion | -2.87 Billion | 4.78 Billion | 7.79 Billion | -248.18 Million |
| Debt repayment | -71.62 Billion | -60.25 Billion | -10.65 Billion | -6.75 Billion | -8.08 Billion | -371.95 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -49.07 Billion | -1.21 Billion | -357.55 Million | -679.97 Million | - | -307.03 Million |
| Common Stock Issuance | 106.9 Billion | - | 100.85 Million | 142.27 Million | 39.85 Million | -5.25 Million |
| Other Financing Activities | 83.16 Billion | 15 Million | 8.03 Billion | 13.64 Billion | 15.84 Billion | 495.71 Million |
| Accounts receivables | 375.71 Million | -1.34 Billion | -1.25 Billion | 4.03 Billion | 278.05 Million | -240.53 Million |
| Accounts payables | -87.26 Million | 1.1 Billion | -1.06 Billion | -4.07 Billion | -403.74 Million | -904.78 Million |
| Inventory | -57.69 Million | 481.74 Million | 2.69 Billion | 5.3 Billion | -433.79 Million | 401.13 Million |
| Other working capital | -1.35 Billion | -1.31 Billion | 3.17 Billion | 501.09 Million | 998.47 Million | -712.33 Million |
| Cash at beginning of period | 55.56 Billion | 16.76 Billion | 23.58 Billion | 30.97 Billion | 32.03 Billion | 30.37 Billion |
| Cash at end of period | 48.1 Billion | 55.56 Billion | 16.76 Billion | 16.76 Billion | 23.58 Billion | 32.03 Billion |
| Capital Expenditure | -9.86 Billion | -4.54 Billion | -9.16 Billion | -21.52 Billion | -4.7 Billion | -4.12 Billion |
| Effect of forex changes on cash | 3.46 Million | 2.57 Million | -96.71 Million | -97.04 Million | -371.04 Thousand | -70.43 Thousand |
| Net cash flow / Change in cash | -7.46 Billion | 38.8 Billion | -6.81 Billion | -14.2 Billion | -8.45 Billion | 1.65 Billion |
| Free Cash Flow | -24.35 Billion | -10.01 Billion | -13.42 Billion | -31.53 Billion | -8.59 Billion | -9.54 Billion |
1539
BPO-PE
FTT
5274
8215
TOH